Purchases and Sales Made in Q2 2024 in Immunity Bio, Inc. (IBRX)
This table provides information about the institutional ownership of Immunity Bio, Inc. (IBRX) during Q2 2024. The information is specifically focused on institutions that hold shares of ImmunityBio, Inc..
| Report Date | Institution (Fund) | Operation | Option | Shares change | Value Range | Shares Held | Trade History |
|---|---|---|---|---|---|---|---|
|
Aug 14, 2024
Q2 2024
|
Barclays PLC
London, X0 |
SELL
|
- |
-227K- 58.83% |
$1.09M - $2.08M
|
159K
$408K
|
|
|
Aug 12, 2024
Q2 2024
|
Jpmorgan Chase & CO
New York, NY |
SELL
|
- |
-252K- 17.57% |
$1.22M - $2.31M
|
1.18M
$3.04M
|
|
|
Jul 30, 2024
Q2 2024
|
Sheets Smith Wealth Management
|
SELL
|
- |
-280K- 29.58% |
$1.35M - $2.56M
|
666K
$1.71M
|
|
|
Aug 13, 2024
Q2 2024
|
Ubs Group Ag
|
SELL
|
- |
-467K- 50.49% |
$2.25M - $4.28M
|
458K
$1.18M
|
|
|
Aug 13, 2024
Q2 2024
|
Rafferty Asset Management, LLC
New York, NY |
SELL
|
- |
-875K- 66.75% |
$4.22M - $8M
|
436K
$1.12M
|
|
|
Aug 12, 2024
Q2 2024
|
Citigroup Inc
|
SELL
|
- |
-1.02M- 90.34% |
$4.91M - $9.33M
|
109K
$280K
|
|
|
Aug 13, 2024
Q2 2024
|
Invesco Ltd.
Atlanta, GA |
SELL
|
- |
-1.21M- 95.18% |
$5.81M - $11M
|
61K
$157K
|
|
|
Aug 14, 2024
Q2 2024
|
State Street Corp
Boston, MA |
SELL
|
- |
-6.32M- 44.56% |
$30.5M - $57.8M
|
7.86M
$20.2M
|